SPOTLIGHT -
Not just a nuisance, no-shows are an opportunity to turn things around for patients with bipolar disorder, whose treatment adherence hovers around 60%.
Goodbye Noncompetes: Federal Trade Commission Votes to Ban Noncompete Clauses
Blue Light, Depression, and Bipolar Disorder
FDA Approves Fanapt for Mixed, Manic Episodes Associated With Bipolar I Disorder
Four Myths About Lamotrigine
Bipolar Disorder Research Roundup: March 29, 2024
Recap: Mood Disorders 2024